Core Scientific (CORZ) reported second-quarter 2026 revenue of $164.2 million, compared with $115.2 million in Q1 2026 and $78.6 million in Q2 2025. The company posted a net loss of $1.16 billion, which it said was primarily driven by the change in fair value of warrants as its stock price appreciated during the period.
The digital infrastructure company said it increased total leased customer power capacity to approximately 1.1 GW, representing more than $24 billion of potential contracted revenue. Core Scientific also announced an AMD partnership with potential to support up to 2.5 GW of leasable capacity.
- Q2 total revenue was $164.2 million, including $136.7 million of colocation revenue.
- Net loss was $1.16 billion, or $3.32 per share, basic and diluted.
- Gross profit was $70.0 million, compared with $30.1 million in Q1 2026.
- Billing MW rose to 395 in Q2 2026 from 225 in Q1 2026.
- Liquidity was $1.82 billion at quarter end, comprising cash, cash equivalents and digital assets.
- Core Scientific said it was billing for 437 MW of capacity as of mid-July, representing about $635 million in average annualized colocation GAAP revenue.
